메뉴 건너뛰기




Volumn 36, Issue 1, 2016, Pages 26-37

Comparative Cardiovascular and Cerebrovascular Safety of Inhaled Long-Acting Bronchodilators in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study

Author keywords

cardiovascular safety; cerebrovascular safety; chronic obstructive pulmonary disease; cohort study; inhaled long acting bronchodilators

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; DELAYED RELEASE FORMULATION;

EID: 84960918161     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/phar.1684     Document Type: Article
Times cited : (19)

References (36)
  • 1
    • 0003661906 scopus 로고    scopus 로고
    • World Health Organization. Available from. Accessed July 5, 2014
    • World Health Organization. World Health Statistics 2008. Available from http://www.who.int/whosis/whostat/2008/en/. Accessed July 5, 2014.
    • World Health Statistics 2008
  • 2
    • 0027962628 scopus 로고
    • Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study
    • Anthonisen NR, Connett JE, Kiley JP, et al., Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272: 1497-505.
    • (1994) JAMA , vol.272 , pp. 1497-1505
    • Anthonisen, N.R.1    Connett, J.E.2    Kiley, J.P.3
  • 3
    • 27144461153 scopus 로고    scopus 로고
    • COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program
    • Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD,. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005; 128: 2068-75.
    • (2005) Chest , vol.128 , pp. 2068-2075
    • Sidney, S.1    Sorel, M.2    Quesenberry, C.P.3    DeLuise, C.4    Lanes, S.5    Eisner, M.D.6
  • 4
    • 28944436527 scopus 로고    scopus 로고
    • Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients
    • Curkendall SM, DeLuise C, Jones JK, et al., Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16: 63-70.
    • (2006) Ann Epidemiol , vol.16 , pp. 63-70
    • Curkendall, S.M.1    DeLuise, C.2    Jones, J.K.3
  • 5
    • 0037465734 scopus 로고    scopus 로고
    • Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? the potential role of systemic inflammation in chronic obstructive pulmonary disease
    • Sin DD, Man SFP,. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514-9.
    • (2003) Circulation , vol.107 , pp. 1514-1519
    • Sin, D.D.1    Man, S.F.P.2
  • 6
    • 17644407378 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality
    • Sin DD, Man SFP,. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005; 2: 8-11.
    • (2005) Proc Am Thorac Soc , vol.2 , pp. 8-11
    • Sin, D.D.1    Man, S.F.P.2
  • 9
    • 84879999170 scopus 로고    scopus 로고
    • Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease
    • Gershon A, Croxford R, Calzavara A, et al., Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease. JAMA Intern Med 2013; 173: 1175-85.
    • (2013) JAMA Intern Med , vol.173 , pp. 1175-1185
    • Gershon, A.1    Croxford, R.2    Calzavara, A.3
  • 10
    • 51949090107 scopus 로고    scopus 로고
    • Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease
    • Lee TA, Pickard AS, Au DH, Bartle B, Weiss KB,. Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease. Ann Intern Med 2008; 149: 380-90.
    • (2008) Ann Intern Med , vol.149 , pp. 380-390
    • Lee, T.A.1    Pickard, A.S.2    Au, D.H.3    Bartle, B.4    Weiss, K.B.5
  • 11
    • 33847172367 scopus 로고    scopus 로고
    • Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
    • Calverley PMA, Anderson JA, Celli B, et al., Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-89.
    • (2007) N Engl J Med , vol.356 , pp. 775-789
    • Calverley, P.M.A.1    Anderson, J.A.2    Celli, B.3
  • 12
    • 84871362143 scopus 로고    scopus 로고
    • Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications
    • Singh S, Loke YK, Enright P, Furberg CD,. Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications. Thorax 2013; 68: 114-6.
    • (2013) Thorax , vol.68 , pp. 114-116
    • Singh, S.1    Loke, Y.K.2    Enright, P.3    Furberg, C.D.4
  • 13
    • 52449106502 scopus 로고    scopus 로고
    • Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease. A systematic review and meta-analysis
    • Singh S, Loke YK, Furberg CD,. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease. A systematic review and meta-analysis. JAMA 2008; 300: 1439-50.
    • (2008) JAMA , vol.300 , pp. 1439-1450
    • Singh, S.1    Loke, Y.K.2    Furberg, C.D.3
  • 14
    • 68849127359 scopus 로고    scopus 로고
    • Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease
    • Lee TA, Wilke C, Joo M, et al., Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Arch Intern Med 2009; 169: 1403-10.
    • (2009) Arch Intern Med , vol.169 , pp. 1403-1410
    • Lee, T.A.1    Wilke, C.2    Joo, M.3
  • 15
    • 53749102775 scopus 로고    scopus 로고
    • A 4-year trial of tiotropium in chronic obstructive pulmonary disease
    • Tashkin DP, Celli B, Senn S, et al., A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 1543-54.
    • (2008) N Engl J Med , vol.359 , pp. 1543-1554
    • Tashkin, D.P.1    Celli, B.2    Senn, S.3
  • 17
    • 79955764009 scopus 로고    scopus 로고
    • Comparison of inhaled long-acting β agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease
    • Gershon A, Croxford R, To T, et al., Comparison of inhaled long-acting β agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease. Ann Intern Med 2011; 154: 583-92.
    • (2011) Ann Intern Med , vol.154 , pp. 583-592
    • Gershon, A.1    Croxford, R.2    To, T.3
  • 18
    • 36448935172 scopus 로고    scopus 로고
    • Comparative safety of long-acting inhaled bronchodilators. A cohort study using the UK THIN primary care database
    • Jara M, Lanes SF, Wentworth C 3rd, May C, Kesten S,. Comparative safety of long-acting inhaled bronchodilators. A cohort study using the UK THIN primary care database. Drug Saf 2007; 30: 1151-60.
    • (2007) Drug Saf , vol.30 , pp. 1151-1160
    • Jara, M.1    Lanes, S.F.2    Wentworth, C.3    May, C.4    Kesten, S.5
  • 19
    • 84863657697 scopus 로고    scopus 로고
    • A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD
    • pii: e000841
    • Jara M, Wentworth C, Lanes S,. A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD. BMJ Open 2012; 2:pii: e000841.
    • (2012) BMJ Open , vol.2
    • Jara, M.1    Wentworth, C.2    Lanes, S.3
  • 21
    • 70350096410 scopus 로고    scopus 로고
    • Identifying individuals with physician diagnosed COPD in health administrative databases
    • Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T,. Identifying individuals with physician diagnosed COPD in health administrative databases. COPD 2009; 6: 388-94.
    • (2009) COPD , vol.6 , pp. 388-394
    • Gershon, A.S.1    Wang, C.2    Guan, J.3    Vasilevska-Ristovska, J.4    Cicutto, L.5    To, T.6
  • 22
    • 61449524241 scopus 로고    scopus 로고
    • Observational studies analyzed like randomized experiments: An application to postmenopausal hormone therapy and coronary heart disease
    • Hernán MA, Alonso A, Logan R, et al., Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology 2008; 19: 766-79.
    • (2008) Epidemiology , vol.19 , pp. 766-779
    • Hernán, M.A.1    Alonso, A.2    Logan, R.3
  • 23
    • 17844393082 scopus 로고    scopus 로고
    • Readers' guide to critical appraisal of cohort studies: 2. Assessing potential for confounding
    • Mamadani M, Sykora K, Li P, et al., Readers' guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 2005; 330: 960-2.
    • (2005) BMJ , vol.330 , pp. 960-962
    • Mamadani, M.1    Sykora, K.2    Li, P.3
  • 24
    • 84877682284 scopus 로고    scopus 로고
    • Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease
    • Tashkin DP, Ferguson GT,. Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease. Respir Res 2013; 14: 49.
    • (2013) Respir Res , vol.14 , pp. 49
    • Tashkin, D.P.1    Ferguson, G.T.2
  • 25
    • 79953166862 scopus 로고    scopus 로고
    • Tiotropium versus salmeterol for the prevention of exacerbations of COPD
    • Vogelmeier C, Hederer B, Glaab T, et al., Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med 2011; 364: 1093-103.
    • (2011) N Engl J Med , vol.364 , pp. 1093-1103
    • Vogelmeier, C.1    Hederer, B.2    Glaab, T.3
  • 26
    • 84871396857 scopus 로고    scopus 로고
    • Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: Systematic review and mixed treatment comparison meta-analysis of randomized controlled trials
    • Dong YH, Lin HH, Shau WY, Wu YC, Chang CH, Lai MS,. Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomized controlled trials. Thorax 2013; 68: 48-56.
    • (2013) Thorax , vol.68 , pp. 48-56
    • Dong, Y.H.1    Lin, H.H.2    Shau, W.Y.3    Wu, Y.C.4    Chang, C.H.5    Lai, M.S.6
  • 27
    • 34247561439 scopus 로고    scopus 로고
    • Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: A randomized trial
    • Aaron SD, Vandemheen KL, Fergusson D, et al., Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2007; 146: 545-55.
    • (2007) Ann Intern Med , vol.146 , pp. 545-555
    • Aaron, S.D.1    Vandemheen, K.L.2    Fergusson, D.3
  • 28
    • 84865284777 scopus 로고    scopus 로고
    • Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: A randomised, double-blind comparison
    • Mahler DA, D'Urzo A, Bateman ED, et al., Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison. Thorax 2012; 67: 781-8.
    • (2012) Thorax , vol.67 , pp. 781-788
    • Mahler, D.A.1    D'Urzo, A.2    Bateman, E.D.3
  • 31
    • 84877131237 scopus 로고    scopus 로고
    • Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): A randomized, double-blind, parallel-group study
    • Wedzicha JA, Decramer M, Ficker JH, et al., Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomized, double-blind, parallel-group study. Lancet Respir Med 2013; 1: 199-209.
    • (2013) Lancet Respir Med , vol.1 , pp. 199-209
    • Wedzicha, J.A.1    Decramer, M.2    Ficker, J.H.3
  • 33
    • 84880229392 scopus 로고    scopus 로고
    • Dual bronchodilation with QVA149 versus single bronchodilator therapy: The SHINE study
    • Bateman ED, Ferguson GT, Barnes N, et al., Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study. Eur Respir J 2013; 42: 1484-94.
    • (2013) Eur Respir J , vol.42 , pp. 1484-1494
    • Bateman, E.D.1    Ferguson, G.T.2    Barnes, N.3
  • 35
    • 84926409166 scopus 로고    scopus 로고
    • Clinical and lifestyle-related risk factors for incident multimorbidity: 10-year follow-up of Finnish population-based cohorts 1982-2012
    • Wikström K, Lindström J, Harald K, Peltonen M, Laatikainen T,. Clinical and lifestyle-related risk factors for incident multimorbidity: 10-year follow-up of Finnish population-based cohorts 1982-2012. Eur J Intern Med 2015; 26: 211-6.
    • (2015) Eur J Intern Med , vol.26 , pp. 211-216
    • Wikström, K.1    Lindström, J.2    Harald, K.3    Peltonen, M.4    Laatikainen, T.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.